Ken Griffin acquired 1.01 Million Angiodynamic shares worth $6.2 Million. That's 0.01% of their equity portfolio (1379th largest holding). The investor owns 2.28% of the outstanding Angiodynamic stock. The first Angiodynamic trade was made in Q1 2014. Since then Ken Griffin bought shares 35 more times and sold shares on 28 occasions. The investor's estimated purchase price is $12.9 Million, resulting in a loss of 52%.